Scroll Back to Top
Accessibility
Accessibility
November 4, 2025

Better Together: Exploring the Synergy of Germline and Somatic Testing for Treating and Managing Cancer

This session explores how somatic and germline genetic testing in oncology can enable more comprehensive insights into cancer biology and treatment. Traditionally, these two testing modalities have been performed independently, limiting the scope of data that can inform clinical decisions. We aim to demonstrate the clinical utility of integrating somatic and germline data to guide therapeutic decisions, particularly for cancers where germline and somatic variants influence treatment.
Read more »
October 15, 2025

How 45 seconds can help save lives: A framework for effective cancer screening conversations in primary care

Primary care providers play a pivotal role in cancer prevention, yet integrating these conversations into busy clinical workflows can be challenging. This session offers a practical, time-efficient framework for discussing cancer screening during routine visits—even when patients present with acute concerns that need to be addressed first. Join us to explore strategies that support shared decision-making and empower patients with personalized prevention plans.
Read more »

Labcorp Perspectives Oncology (Episode 6): Empowering breast cancer patients: Biomarker breakthroughs and self-advocacy

When Suzanne Garner was diagnosed with breast cancer at age 40, she wasn’t a medical expert, but she quickly became one of her own best advocates. On the latest episode of Labcorp Perspectives: Oncology, host Dr. Rebecca Previs  talks with Suzanne, now Senior Director of Strategic Partnerships at Outcomes4Me, about her transformation from newly diagnosed patient to digital-health leader.

Read more »

Executive Q&A - Empowering Diagnostic Clarity in Hematologic Malignancies

 

Each year, NGS testing becomes increasingly important for identifying subtypes and treatment options in hematologic malignancies.

In this Executive Q&A video, medical director of Labcorp's Brentwood, Tennessee Stephanie McAlhany, discusses the lab's hematology testing, and about the support they offer in choosing tests and interpreting results.

 

Read more »

Molecular Tumor Board: 71-year-old male with gastrointestinal stromal tumor and KIT A502_Y503dup

In this recent Molecular Tumor Board, our Medical Affairs team reviewed a case of gastrointestinal stromal tumor (GIST) with a confirmed KIT mutation, highlighting how NGS-based Comprehensive Genomic Profiling (CGP) informs treatment. The discussion explored the biology of the kinase family and how molecular testing can differentiate alterations that may be sensitive or resistant to specific kinase inhibitors. This case underscores the power of precision medicine in guiding targeted therapy and improving outcomes in GIST.

Read more »
Subscribe to Watch